News About: Goverment
KFDA to institutionalize new GMP regulations until 2010
The Food and Drug Administration (KFDA) announced recently it will implement, by phase, a new current good manufacturing practice (cGMP) system until 2010 in a bid to upgrade its GMP level to that of advanced countrie...
NHI price in harsh disputes between NHIC and groups.
The medical and pharmaceutical groups and the National Health Insurance Corporation (NHIC) faced with a serious conflict on the contract of the NHI reimbursement prices
6 medical and pharmaceutical groups, the Kor...
Pharmacy to face sanction for sales points
Proprietors of pharmacy will be subject to punishment for discounting the price of medicines on card holders using sales points offered by some pharmacies to enable them to use the points like cash when they purchase ...
New drug labelling to raise big changes in drug industries.
The MOHW is going to revise the Working Rules of the Pharmaceutical Affairs Act so that all drug packages should show its shelf lives and lot numbers for the local made drugs, and the manufacturer's names on the packa...
742 combined drugs to be in non-NHI reimbursement scheme.
As planned 742 combined drugs are excluded from the NHI reimbursement schedule taking effects from Nov. 1., under which many of them seem to be returned in fear of idle stocks at the pharmacy shelf.
The Drug Revie...
Local clinical studies at a level of advanced countries.
To upgrade the local clinical studies the government regulatory plans to reinforce the clinical study inspection and its safety controls, including more educational programs for the study researchers and an establishm...
Use of standardized oriental medicines eyed
Oriental clinics and hospitals will be obliged to use oriental medicines listed in the compendium of natural preparations, the Ministry of Health and Welfare said recently.
According to the newly revised medical la...
Domestic pharmaceutical firms stingy on R&D
Korean pharmaceutical companies are spending little money on research and development (R&D) activities as they focus more on marketing and advertisement outlays, a lawmaker said recently citing government statisti...
Korea do not accept extension of patent period by 5 years
The Ministry of Health and Welfare said The Korean government has not promised to accept the U.S. government's requests regarding an extension of the patent period by five years for their drugs to increase their price...
Mandatory ingredient labeling system for cosmetics eyed
A regulation requiring cosmetic products sold in Korea to list all ingredients on the label is under review, according to the Korea Food and Drug Administration (KFDA).
To that end, a working-level team consisting ...